Spontaneous pregnancies and premature menopause

Gynécologie, obstétrique & fertilité
H LeturGEDO

Abstract

Hypoestrogenic hypergonadotrophic amenorrhea occurring before the age of 40 years is generally considered irreversible. The term "premature menopause" used to define this condition seems a misnomer, and "premature ovarian failure" (POF) is preferred on both a psychological and a physiological basis. POF is not uncommon considering the incidence rate of 1-2% of women during their theoretically reproductive life. These circumstances are particularly painful when a child is desired. However, since a long time the notion of permanent cessation of ovarian function is challenged and intermittent and transient return of ovarian function has been described with 5-10% chance of pregnancy often more than 12 months after the beginning of the amenorrheic status. A multicentric retrospective study conducted by the GEDO reports 27 pregnancies out of 518 patients waiting for an in vitro fertilization with oocyte donation because of POF or occult ovarian insufficiency. Considering this work and a literature review, we try to propose part of understanding of the basic POF physiopathology, and to examine the factors which could act on the prognosis and the clinical management.

References

Dec 1, 1992·American Journal of Obstetrics and Gynecology·G F TideyR J Stillman
Jan 1, 1990·The Journal of Clinical Endocrinology and Metabolism·J L LuborskyA DeCherney
Jan 1, 1990·International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists·P BannatyneR P Shearman
Jul 1, 1989·American Journal of Obstetrics and Gynecology·L Tang, R S Sawers
Apr 1, 1988·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·T R Varma, R H Patel
Jan 1, 1988·American Journal of Obstetrics and Gynecology·F S CowchockB B Montgomery
Apr 1, 1986·Obstetrics and Gynecology·C B CoulamJ F Annegers
Feb 1, 1984·British Journal of Obstetrics and Gynaecology·A C RobinsonE C Sweeney
Nov 1, 1984·European Journal of Obstetrics, Gynecology, and Reproductive Biology·M NakaiM Arai
Nov 1, 1984·American Journal of Human Genetics·D R MattisonJ D Schulman
Mar 1, 1995·Obstetrics and Gynecology·G S CooperC L Hughes
Feb 1, 1996·Fertility and Sterility·G S ConwayH S Jacobs
Jul 12, 1996·Cell·C BarlowA Wynshaw-Boris
Mar 1, 1996·Human Reproduction Update·H BilligA J Hsueh
Jun 1, 1997·Current Opinion in Obstetrics & Gynecology·G S Conway
Jul 11, 1998·Fertility and Sterility·J N Anasti
Jan 29, 1999·Endocrinology and Metabolism Clinics of North America·S N KalantaridouL M Nelson
Jul 7, 1999·Lancet·P FénichelS Hiéronimus
Jul 10, 1999·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·T LamlB W Hartmann
Mar 21, 2000·American Journal of Human Genetics·R D HundscheidA P Smits
Oct 30, 2003·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Bhaumik PatelVed V Gossain
Mar 17, 2007·Journal of Obstetrics and Gynaecology : the Journal of the Institute of Obstetrics and Gynaecology·P Sinha, N Kuruba

❮ Previous
Next ❯

Citations

Jul 29, 2008·Gynécologie, obstétrique & fertilité·J Belaisch-AllartH Moumin
Jul 8, 2005·The New England Journal of Medicine·Rogerio A Lobo
Aug 30, 2005·Gynécologie, obstétrique & fertilité·P Fénichel
Jul 29, 2008·Current Opinion in Obstetrics & Gynecology·Maud BidetPhilippe Touraine

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis